Last Posted: Jan 16, 2020
- Assessment of laboratories offering cell-free (cf) DNA screening for Down syndrome: results of the 2018 College of American Pathology External Educational Exercises.
Palomaki Glenn E et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Jan - A Retrospective Analysis of 10-Year Data Assessed the Diagnostic Accuracy and Efficacy of Cytogenomic Abnormalities in Current Prenatal and Pediatric Settings.
Chai Hongyan et al. Frontiers in genetics 2019 101162 - Multi-institutional experience of genetic diagnosis in Ecuador: National registry of chromosome alterations and polymorphisms.
Paz-Y-Miño César et al. Molecular genetics & genomic medicine 2019 Dec e1087 - Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis.
Zhang Wei et al. PloS one 2019 14(12) e0225281 - Translating translation in Down syndrome
M Halliday et al, Science, November 2019 - Progress in pediatrics in 2015: choices in allergy, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, nephrology, neurology, nutrition, oncology and pulmonology.
Caffarelli Carlo et al. Italian journal of pediatrics 2016 Aug 42(1) 75 - Psychological and social consequences of non-invasive prenatal testing (NIPT): a scoping review.
Labonté Valérie et al. BMC pregnancy and childbirth 2019 Oct 19(1) 385 - Non-Invasive Prenatal Testing beyond Trisomies.
Suciu Ioan Dumitru et al. Journal of medicine and life 12(3) 221-224 - Contemporary prenatal aneuploidy screening practice in Australia: Frequently asked questions in the cell-free DNA era.
Rieder Wawrzyniec et al. The Australian & New Zealand journal of obstetrics & gynaecology 2018 58(4) 397-403 - An Analytical Mobile App for Shared Decision Making About Prenatal Screening: Protocol for a Mixed Methods Study.
Abbasgholizadeh Rahimi Samira et al. JMIR research protocols 2019 Oct 8(10) e13321
.png)
No hay comentarios:
Publicar un comentario